Stay updated on Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.

Latest updates to the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' was removed. This indicates an update to the study documentation version, typically reflecting administrative edits rather than changes to core study content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new page revision label, v3.5.3, was added and the previous v3.5.2 label removed, signaling a minor version update to the study page. This reflects a backend or UI refresh rather than changes to the trial details themselves.SummaryDifference0.0%

- Check45 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check109 days agoChange DetectedThe page now shows a new revision banner 'Revision: v3.4.2' and removes older funding/operating notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.